James J. Marino's Insider Trades & SAST Disclosures
James J. Marino's most recent trade in Celldex Therapeutics Inc. was a trade of 10,500 Common Stock done . Disclosure was reported to the exchange on Nov. 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James J. Marino.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | James J. Marino | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Nov 2024 | 10,500 | 2,204 (0%) | 0% | 0 | Common Stock | |
| Celldex Therapeutics Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 16,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Traws Pharma Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Celldex Therapeutics Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 11,300 | 11,300 | - | - | Non-Qualified Stock Option (right to buy) | |
| Traws Pharma Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 66,468 | 66,468 | - | - | Stock Option (right to purchase) | |
| Celldex Therapeutics Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 13,600 | 13,600 | - | - | Non-Qualified Stock Option (right to buy) | |
| PVH Corp | V. James Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 3,061 | 31,278 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Traws Pharma Inc. | James J. Marino | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 28 Sep 2021 | 5,952 | 21,334 (0%) | 0% | 4.2 | 24,998 | Common Stock |
| Traws Pharma Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 13,000 | 13,000 | - | - | Stock Option (right to purchase) | |
| Celldex Therapeutics Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| PVH Corp | V. James Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,521 | 28,217 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Traws Pharma Inc. | James J. Marino | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 16 Feb 2021 | 25,000 | 230,716 (0%) | 0% | 1 | 25,000 | Common Stock |
| Traws Pharma Inc. | James J. Marino | Director | Purchase of securities on an exchange or from another person at price $ 0.26 per share. | 24 Nov 2020 | 38,774 | 205,716 (0%) | 0% | 0.3 | 10,004 | Common Stock |
| PVH Corp | V. James Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 1,076 | 26,696 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Traws Pharma Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 125,000 | 125,000 | - | - | Stock Appreciation Right | |
| Celldex Therapeutics Inc. | James J. Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 11,000 | 11,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| PVH Corp | V. James Marino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 1,770 | 25,620 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Celldex Therapeutics Inc. | James J. Marino | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 09 Jun 2020 | 8,305 | 12,704 (0%) | 0% | 3 | 24,915 | Common Stock, par value $0.001 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges